Working with multidisciplinary teams and educating patients are key to treating patients with cancer while navigating newly approved treatments.
The US Oncology Network (The Network) has developed one of the most comprehensive programs in the nation to support the professional development and retention of new oncology nurses.
The subcutaneous formulation of nivolumab showed comparable efficacy and safety to the IV formulation in advanced clear cell renal cell carcinoma.
Per phase 2 trial data, enhanced dermatologic management showed a reduction in dermatologic AEs in patients with advanced EGFR-mutated NSCLC.
Closing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.
An oncology social worker reflects on a day in the life and how the memory of her sister motivates her to tackle her work.
Receiving a breast cancer diagnosis and undergoing treatment as a young adult takes a physical and emotional toll.
Sheila Ridner, PhD, RN, FAAN, discusses the implications of the PREVENT study and how oncology nurses can advocate for patients with breast cancer.
New Division in the Department of Biomedical Sciences Conducts Translational Research and Engages With Community to Help Reduce the Burden of Disease and Improve Quality of Life.
A tiered level preceptor recognition program offers a cost-effective organizational intervention designed to acknowledge and incentivize the contributions of advanced practice preceptors.
Elizabeth Loach, MSN, APRN, CNS, AGCNS-BC, OCN, discusses the importance of including frontline nurses in nursing leadership task forces.
Entering the words nutrition and cancer into Google returns as many as 718 million hits. With an overabundance of opinions, it can be challenging to separate fact from fiction.
A lung cancer screening navigator offers their perspective on shared decision-making.
In myeloma treatment, acute CRS is a common but treatable AE associated with CAR T-cell therapy and bispecific antibodies, according to a nurse practitioner.
Oncology nurses and APPs provide support and can help to facilitate conversations with patients and families during end-of-life care.
"Differential diagnoses in patients with bicytopenia—particularly those with preserved platelets—are broad and require careful physical examination."
Kelly L. Garvin, BSN, RN, OCN, discusses what changes she hopes to see in CAR T-Cell therapy treatment over the coming years.
Patients treated with ide-cel, Abecma for relapsed/refractory multiple myeloma affecting the central nervous system had similar outcomes to matched patients with non-CNS multiple myeloma.
Patients with metastatic hormone-sensitive prostate cancer experienced increase rPFS and other efficacy end points with darolutamide plus ADT.
A lung cancer screening navigator offers their perspective on shared decision-making.
Difficult conversations in cancer pain management should include core values and principles, setting realistic expectations, and building the patient-client relationship from the very beginning.
Closing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.
Experts discuss optimizing renal cell carcinoma (RCC) treatment by integrating patient-reported outcomes and clinician insights.
“We've had to develop a unique process and a unique cryo buffer that allows us to freeze natural killer cells and recover greater than 90% of those cells. So, the new GDA-201 cryo-preserved is now going to be an off-the-shelf product and we're going to reinstitute a multicenter study in lymphoma to include both histologies of follicular lymphoma and diffuse large B cell lymphoma.”
Dr Mohan engages with Dr Mann, Nurse Brigle, Nurse Distaso, and Dr Nadeem to explore challenges in the referral process for bispecific therapy, including local health care barriers, and strategies for ensuring consistent patient education and support when care is shared between community and academic centers.
The 3 fundamental coping mechanisms patients should have embedded into their care plan are self-compassion, gratitude, and kindness.
Adolescent and young adult survivors of cancer face increased substance use risks due to developmental delays, limited support, and coping mechanisms, necessitating targeted prevention.
As prognoses continue to improve, concerns about treatment-associated fertility risks are becoming more prevalent and are often a topic of discussion between patients and their nurses or nurse practitioners.
Experts share insights on standard work-up and staging practices for a patient with newly diagnosed bladder cancer.